Dogwood Therapeutics Inc.

DWTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.63

-$0.06 (-3.55%)

At close: Sep 21, 2026, 3:59 PM ET

$1.72

+$0.09 (+5.52%)

Pre-market: Sep 22, 2026, 6:44 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.55%

(1D)

Rating

Updated: Sep 1, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $54.82M

1D Range

1.58 1.74

52W Range

1.28 9.50

Valuation (TTM)

PE -0.18

PB 0.80

EV/EBITDA -1.55

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target $12

Cash Flow

FCF Yield -27.6%

SBC Adj. FCF Yield -27.9%

SBC Impact -1.4%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -13.9% | 39.2%

FCF 3Y | 5Y -46.8% | -8.9%

Returns

ROA -44.8%

ROE -47.9%

ROIC -35.6%

Financial Health

Net Cash

$9.55M

Current Ratio 3.89

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Dogwood Therapeutics, Inc. is an emerging biotechnology firm dedicated to creating innovative antiviral treatments. Their primary goal is to address illnesses that stem from atypical immune reactions ...

Sector Healthcare

Industry Biotechnology

Employees 8

IPO Date Dec 16, 2020

Website www.dwtx.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$12

Upside

+636.20%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞